IGSF8 anticorps (Middle Region)
Aperçu rapide pour IGSF8 anticorps (Middle Region) (ABIN929376)
Antigène
Voir toutes IGSF8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- IGSF8 antibody was raised in rabbit using the middle region of IGSF8 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
IGSF8 Blocking Peptide, (ABIN940191), is also available for use as a blocking control in assays to test for specificity of this IGSF8 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- IGSF8 (Immunoglobulin Superfamily, Member 8 (IGSF8))
-
Autre désignation
- IGSF8
-
Sujet
- IGSF8 may play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. IGSF8 may regulate proliferation and differentiation of keratinocytes. IGSF8 may be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. IGSF8 may also play a role on integrin-dependent morphology and motility functions. IGSF8 may participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain. Synonyms: Polyclonal IGSF8 antibody, Anti-IGSF8 antibody, immunoglobulin superfamily, member 8 antibody, CD316 antibody, CD81P3 antibody, EWI2 antibody, PGRL antibody.
Antigène
-